Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Cogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology
(NASDAQ: CGNT) Delayed: 8.17 +0.04 (0.49%)
Previous Close $8.13    52 Week High $2.48 
Open $8.13    52 Week Low $0.71 
Day High $8.26    P/E N/A 
Day Low $8.11    EPS $0.00 
Volume 139,100